Food and Drug Administration
Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics is a funding opportunity from Food and Drug Administration.
Overview
The goal of this funding opportunity announcement is to support applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics. The main outcomes of this work will be publications and presentations; however, FDA staff anticipate substantial involvement in study design and reviewing…